Intra-Cellular Therapies, Inc.
2019 Q4 - 2025 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q1 | 5/15/2025 | 12,154 | 0.0% | 92,133 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 7,481 | 0.0% | 89,567 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 6,623 | 0.0% | 90,511 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 5,917 | 0.0% | 86,386 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 6,079 | 0.0% | 87,844 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 6,621 | 0.0% | 92,450 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 5,054 | 0.0% | 97,021 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 6,752 | 0.0% | 106,626 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 5,900 | 0.0% | 108,964 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 5,847 | 0.0% | 110,496 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 5,082 | 0.0% | 109,226 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 6,282 | 0.0% | 110,059 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 6,378 | 0.0% | 104,232 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 5,069 | 0.0% | 96,842 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 3,529 | 0.0% | 94,668 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 3,976 | 0.0% | 97,406 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 3,395 | 0.0% | 100,048 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 3,191 | 0.0% | 100,349 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 2,538 | 0.0% | 98,925 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,129 | 0.0% | 82,930 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,231 | 0.0% | 80,096 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 2,334 | 0.0% | 68,016 | 12/31/2019 |